Will Anthropic's valuation hit (HIGH) $1.25T by December 31?

Prediction markets put the probability at 90%: Will Anthropic's valuation hit (HIGH) $1.25T by December 31. Currently, markets see this as likely (90% YES). CNBC Daily Open: Anthropic unbound, Trump's finances and crude realities.

What’s Happening

Prediction market participants are assigning a 90% probability that Anthropic's valuation will hit the $1.25 trillion mark by December 31, 2026, reflecting a surge of confidence following a series of major corporate and product developments. The AI lab recently secured what analysts describe as its biggest win of the year, a landmark enterprise contract that bolsters its revenue trajectory just weeks after launching Claude Sonnet 5 at a steep discount to its flagship model. That product release, combined with the debut of Claude Science for the healthcare sector on June 30, signals an aggressive push to capture market share across verticals as the company barrels toward a blockbuster initial public offering. The market's current 90% YES stance on Anthropic's valuation hit (high) $1.25t by December 31 suggests investors see these catalysts as sufficient to justify a tripling of the firm's worth from its last private round within six months. [CNBC, Jul 01] [VentureBeat, Jun 30]

The valuation surge narrative is underpinned by Anthropic's strategic pivot toward government and enterprise adoption, even as it navigates a contentious relationship with federal regulators. A July 1 report noted that Anthropic received clearance to roll out its latest AI models to "foreign nationals," a regulatory green light that removes a key barrier to international revenue growth. However, a separate analysis from Investor's Business Daily on July 2 highlighted that rival Palantir Technologies received an analyst upgrade specifically because it is viewed as a "better option for enterprises than OpenAI or Anthropic," citing the latter's "confrontational tact with the U.S. government." This tension creates a dual dynamic: while regulatory wins open new markets, competitive pressure from defense-linked AI firms could cap the pace at which Anthropic scales its valuation. The market's 90% conviction on Anthropic's valuation hit (high) $1.25t by December 31 therefore hinges on whether its product velocity can outrun these headwinds. [Investor's Business Daily, Jul 02] [TheStreet, Jul 04]

Looking ahead, the primary catalyst for achieving a $1.25 trillion valuation will be the pricing and reception of Anthropic's upcoming IPO, which is expected to test whether private market AI valuations can hold in a public listing. The company's recent launch of Claude Sonnet 5 at a mid-tier price point is widely seen as a move to demonstrate scalable revenue to potential institutional investors, while the Claude Science vertical targets the lucrative healthcare AI market. Broader macroeconomic factors also loom: Federal Reserve official Beth Hammack warned on July 1 that AI investment is driving inflation, a signal that interest rates may remain elevated, potentially compressing the multiples that public investors assign

Traded on Polymarket — $151K Volume

Polymarket prices this at 90c YES with $151K in volume. Moderate liquidity — use limit orders for positions above $1K to avoid moving the price.